PRE-EMPTIVE DARATUMUMAB TREATMENT IN ASYMPTOMATIC BIOCHEMICAL RELAPSE CAN PROLONG SURVIVAL IN PATIENTS WITH MULTIPLE MYELOMA: RESULTS OF THE RANDOMIZED, MULTICENTER PREDATOR-BR CLINICAL TRIAL

EHA Library, Krzysztof Jamroziak, 421034

EFFICACY AND SAFETY OF IXAZOMIB PLUS LENALIDOMIDE AS MAINTENANCE FOLLOWING AUTOLOGOUS STEM CELL TRANSPLANTATION(ASCT) IN HIGH RISK NEWLY DIAGNOSED MULTIPLE MYELOMA(NDMM）

EHA Library, Yang Liu, 421035

ASSESSING FRAILTY IN MYELOMA: THE PURSUIT OF SIMPLICITY MAY SACRIFICE PRECISION OF PREDICTING CLINICAL OUTCOMES

EHA Library, Kaz Groen, 421036

BRIDGING STRATEGIES FOR ANTI-BCMA CAR-T CELL THERAPIES IN MULTIPLE MYELOMA PATIENTS WITH PRIOR EXPOSURE TO BISPECIFIC ANTIBODIES

EHA Library, Johannes Waldschmidt, 421037

DARATUMUMAB (DARA)/BORTEZOMIB/LENALIDOMIDE/DEXAMETHASONE (D-VRD) WITH D-R MAINTENANCE (MAINT) IN TRANSPLANT-ELIGIBLE (TE) NEWLY DIAGNOSED MYELOMA (NDMM): ANALYSIS OF PERSEUS BASED ON CYTOGENETIC RISK

EHA Library, Meletios Dimopoulos, 421038

MONOCLONAL PROTEIN DETECTION BY LIQUID CHROMATOGRAPHY MASS SPECTROMETRY (LC-MS) FOR IDENTIFICATION OF EXCEPTIONAL RESPONDERS IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)

EHA Library, Andrzej Jakubowiak, 421039

METABOLIC SYNDROME AND THE RISK OF MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: A POPULATION-BASED SCREENING STUDY IN ICELAND

EHA Library, Kristján Berg Guðmundsson, 421040

IMPACT OF DARA-VTD INDUCTION THERAPY ON HEMATOPOIETIC STEM CELL COLLECTION AND ENGRAFTMENT IN MULTIPLE MYELOMA PATIENTS ELIGIBLE FOR ASCT: RESULTS OF THE PRIMULA STUDY

EHA Library, Vanda Strafella, 421041

CILTACABTAGENE AUTOLEUCEL VS STANDARD OF CARE IN LENALIDOMIDE-REFRACTORY MULTIPLE MYELOMA: PHASE 3 CARTITUDE-4 SUBGROUP ANALYSIS BY CYTOGENETIC RISK

EHA Library, Roberto Mina, 421042

PROSPECTIVE EVALUATION OF 3T WHOLE-BODY MRI AND 18F-FDG PET/CT IN THE MANAGEMENT OF MULTIPLE MYELOMA AND SMOLDERING MYELOMA

EHA Library, Claudio Cerchione, 421043

ISATUXIMAB CYCLOPHOSPHAMIDE BORTEZOMIB AND DEXAMETHASONE INDUCTION AND AUTOLOGOUS STEM CELL TRANSPLANT IN NEWLY DIAGNOSED MYELOMA: REPORT OF THE PROSPECTIVE CANADIAN MYELOMA RESEARCH GROUP 008 TRIAL

EHA Library, Rami Kotb, 421044

EVALUATION OF CYTOKINE RELEASE SYNDROME IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA RECEIVING STEP-UP PRIMING DOSES AND LONGER DOSING INTERVALS OF ELRANATAMAB: MAGNETISMM-9

EHA Library, Charlotte Pawlyn, 421045

PHASE 1/2 TRIAL TO JOINTLY OPTIMIZE DOSE AND ADMINISTRATION SCHEDULE OF EVOMELA IN NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Qaiser Bashir, 421046

BOTH SINGLE AND BIALLELIC TP53 ABERRATIONS PREDICT POOR PROGNOSIS IN MULTIPLE MYELOMA

EHA Library, Romana Nesnadná, 421047

RADIATION THERAPY IN THE MODERN ERA OF MULTIPLE MYELOMA MANAGEMENT: TRENDS OF RT INTEGRATION, PATTERNS OF UTILIZATION, AND RADIOLOGIC, BIOCHEMICAL, AND CYTOGENETIC CORRELATES OF OUTCOME AND RESPONSE

EHA Library, Alexandra Dreyfuss, 421048

COMBINED MASS SPECTROMETRY AND NEXT GENERATION FLOW AS EARLY PREDICTORS OF RESPONSE IN RELAPSED/REFRACTORY MYELOMA PATIENTS TREATED WITH CAR-T CELLS AND T-CELL ENGAGERS

EHA Library, Noemi Puig, 421049

THE PROGNOSTIC IMPACT OF DIFFERENTIAL CIRCULATING TUMOR CELL COUNT IN NEWLY DIAGNOSED PATIENTS WITH AL AMYLOIDOSIS, ASSESSED WITH NEXT-GENERATION FLOW CYTOMETRY

EHA Library, Ioannis Kostopoulos, 421050

A SINGLE-ARM PHASE 2 STUDY EVALUATING THE OPTIMIZED SCHEDULE OF BELANTAMAB MAFODOTIN 1.9 MG/KG Q8W PLUS BORTEZOMIB AND DEXAMETHASONE IN RELAPSED REFRACTORY MULTIPLE MYELOMA

EHA Library, Tereza Popková, 421051

DEVELOPMENT OF A COMPREHENSIVE PROGNOSTIC STRATIFICATION FOR NEWLY DIAGNOSED MULTIPLE MYELOMA INTEGRATING MULTIDIMENSIONAL FACTORS

EHA Library, Lulu Wang, 421052

PROGNOSTIC SIGNIFICANCE OF 1Q21 CHROMOSOMAL ABNORMALITIES IN CLINICAL PRACTICE:  GAIN OR AMPLIFICATION 1Q21 IN MULTIPLE MYELOMA – WHICH ONE IS WORSE?

EHA Library, Aleksandra Sretenovic, 421053

REAL-WORLD SCHEDULE DE-ESCALATION OF TECLISTAMAB IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA – A US NATIONAL HEALTHCARE CLAIMS ANALYSIS

EHA Library, Matthew J. Pianko, 421054

STEM CELL BOOST FOR PERSISTENT CYTOPENIAS AFTER BCMA-DIRECTED CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELL THERAPY

EHA Library, Anupama Kumar, 421055

TECLISTAMAB (TEC) STEP-UP DOSING (SUD) AND TREATMENT DOSE SCHEDULE DE-ESCALATION IN THE REAL-WORLD (RW) SETTING – AN ANALYSIS OF MULTICENTER ELECTRONIC MEDICAL RECORDS

EHA Library, Rahul Banerjee, 421056

FINAL RESULTS OF A PHASE 1 STUDY OF DARATUMUMAB, IXAZOMIB, AND DEXAMETHASONE IN NEWLY DIAGNOSED AND PREVIOUSLY TREATED AL AMYLOIDOSIS

EHA Library, Hans Lee, 421057

ASSESSING THE ROLE OF PRACTICE SETTING ON DISPARITIES IN CLINICAL AND TREATMENT OUTCOMES AMONG PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)

EHA Library, Aster Meche, 421058

SYNCHRONOUS AND SECOND PRIMARY CANCERS IN NEWLY DIAGNOSED MULTIPLE MYELOMA NON-TRANSPLANT-ELIGIBLE TREATED WITH LENALIDOMIDE.

EHA Library, Thomas Systchenko, 421059

LONG TERM OUTCOME OF A SEQUENTIAL RESPONSE-DRIVEN BORTEZOMIB-BASED THERAPY FOLLOWED BY AUTOLOGOUS STEM CELL TRANSPLANT IN AL AMYLOIDOSIS

EHA Library, Marco Basset, 421060

ADAPTIVE FREQUENTIST DESIGNS IN THE RANDOMIZED HOVON-87/NMSG18 CLINICAL TRIAL FOR PATIENTS WITH MULTIPLE MYELOMA

EHA Library, Maarten Seefat, 421061

REAL-WORLD DATA ON THE DARATUMUMAB PLUS BORTEZOMIB, THALIDOMIDE AND DEXAMETHASONE FOLLOWED BY LENALIDOMIDE MAINTENANCE FOR TRANSPLANT-ELIGIBLE NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS

EHA Library, Edvan Crusoe, 421062

NOVEL SELINEXOR TRIPLET AND QUADRUPLET REGIMENS (SND, SPED, SBD, SDPD): RESULTS FROM THE PHASE 1B/2 STOMP MULTIPLE MYELOMA TRIAL

EHA Library, Sumit Madan, 421063

COMPARATIVE ANALYSIS OF NEXT-GENERATION SEQUENCING AND OPTICAL GENOME MAPPING TECHNOLOGIES FOR DETECTING STRUCTURAL VARIANTS AND COPY NUMBER VARIANTS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Marta Portasany, 421064

ASSOCIATION BETWEEN DICER1 RS3742330 AND AGO1 RS636832 POLYMORPHISMS AND ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN AND ADOLESCENTS FROM GREECE: A CASE-CONTROL STUDY

EHA Library, Ioannis Kyriakidis, 421065

RNA-SEQ IS A RELIABLE METHODOLOGY FOR THE RECLASSIFICATION OF PEDIATRIC B-OTHER ACUTE LYMPHOBLASTIC LEUKEMIA INTO NEW GENETIC SUBTYPES

EHA Library, Clara Vicente Garcés, 421066

EXPLORING THE GENOMIC FEATURES OF CML-LIKE PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Fatemah Rezayee, 421067

TRANSCRIPTOMIC LANDSCAPE OF DUX4-REARRANGED B-ALL IN INDIA

EHA Library, Mercilena Benjamin, 421068

DOES MENINGEAL INFILTRATION HEIGHTEN INFLAMMATORY RESPONSE IN B-ACUTE LYMPHOBLASTIC LEUKEMIA?

EHA Library, eya anane, 421069

IMPACT OF MINIMAL RESIDUAL DISEASE AND BLAST COUNT IN RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Aicha Ben kahla, 421070

THERAPEUTIC OUTCOMES OF PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN YOUNG ADULTS

EHA Library, Haifa Hafsa, 421071

MOLECULAR PROFILING OF ALL IN PEDIATRIC PATIENTS TREATED AT SOLCA, GUAYAQUIL. EVALUATION OF PROGNOSTIC VALUE. PRELIMINARY REPORT.

EHA Library, JUAN-CARLOS RUIZ-CABEZAS, 421072

OVERVIEW OF GENES ASSOCIATED WITH LEUKAEMIA IN MIDDLE EASTERN COUNTRIES

EHA Library, Abdulrahman Algarni, 421073

MIXED-PHENOTYPE ACUTE LEUKEMIA: CLINICO-BIOLOGICAL INSIGHTS AND THERAPEUTIC STRATEGIES

EHA Library, Maha Charfi, 421074

ACUTE LYMPHOBLASTIC LEUKEMIA FOLLOWING MAINTENANCE TREATMENT WITH LENALIDOMIDE FOR MULTIPLE MYELOMA EXPERIENCE FROM A CENTER

EHA Library, Alfredo Gomez, 421075

OUTCOME OF HIGH-RISK ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN AND YOUNG ADULTS, EXPERIENCE OF SFAX HEMATOLOGY DEPARTMENT

EHA Library, Imen Ben Amor, 421076

RITUXIMAB AS A SALVAGE TREATMENT FOR MINIMAL RESIDUAL DISEASE (MRD) RELAPSE IN PHILADELPHIA NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA EXPRESSING CD 20 ANTIGEN

EHA Library, Nicola Cecchi, 421077

EFFECT OF ADULTS AND PEDIATRIC-INSPIRED REGIMENS ON NEGATIVE MEASURABLE RESIDUAL DISEASE AND OVERALL SURVIVAL IN ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Christian Ramos Peñafiel, 421078

BONE TISSUE AND IRON METABOLISM IN CHORNOBYL ACCIDENT POST-COME CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA BEFORE AND AFTER CHEMOTHERAPY

EHA Library, Katerina Bruslova, 421079

CLINICAL OBSERVATIONS OF BLINATUMOMAB IN THE TREATMENT OF CHILDREN WITH B-CELL PRECURSOR ACUTE LYMPHOCYTIC LEUKEMIA

EHA Library, Tao Hu, 421080

EFFICIENCY OF MULTI-COURSE BLINATUMOMAB COMBINED WITH REDUCED-DOSE CHEMOTHERAPY IN CHEMO INTOLERANT MEDIUM TO HIGH-RISK PEDIATRIC B-ALL PATIENTS WITH SYSTEMIC FUNGAL DISEASE

EHA Library, Weiqun Xu, 421081

OUTCOMES OF SEQUENTIAL ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION AFTER BLINATUMOMAB IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS WITH LOW OR UNDETECTABLE MINIMAL RESIDUAL DISEASE

EHA Library, Sitian Yang, 421082

EFFECT OF CROSS-TRAINING AND RESISTANCE EXERCISE ON BODY COMPOSITION, PHYSICAL PERFORMANCE, QOL, AND IL-15 OBSERVANCES IN ADULTS WITH DE NOVO ACUTE LYMPHOBLASTIC LEUKEMIA DURING INDUCTION THERAPY.

EHA Library, Adán Gallardo Rodríguez, 421084

SAFETY AND EFFICACY OF MULTIPLE SHORT-COURSE BLINATUMOMAB FOR RELAPSED CD19-POSITIVE B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION

EHA Library, Xinyu Chen, 421085

EFFICACY AND SAFETY OF BLINATUMOMAB IN ADULT PATIENTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A REAL-WORLD STUDY

EHA Library, Xiao-Ning Gao, 421086

AN OPEN-LABEL, SINGLE ARM, MULTICENTER STUDY TO EVALUATE RELMACABTAGENE AUTOLEUCEL, THE CD-19 DIRECTED CAR-T CELL THERAPY, IN PEDIATRIC PATIENTS WITH B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA IN CHINA

EHA Library, Ying Wang, 421087

MULTIPLE SHORT-COURSE TREATMENT OF BLINATUMOMAB CONSOLIDATION THERAPY REDUCES CUMULATIVE RELAPSE RATE IN B-ALL PATIENTS WITH DAY 19 BONE MARROW MRD ≥ 1.0*10-2 UNDER CCCG-ALL 2020 PROTOCOL

EHA Library, Chenyu Weng, 421088

USING ONLINE CONTINUING MEDICAL EDUCATION INITIATIVES TO IDENTIFY ONGOING GAPS IN CLINICIANS’ KNOWLEDGE, COMPETENCE, AND CONFIDENCE MANAGING ASPARAGINASE THERAPIES IN ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Sarah Elizabeth Bomba, 421089

INTRATHECAL RITUXIMAB PLUS DEXAMETHASONE IN TRIPLE THERAPY REFRACTORY SANCTUARY CENTRAL NERVOUS SYSTEM (CNS) INVOLVEMENT IN B-CELL MALIGNANCIES

EHA Library, Maher Salamoon, 421090

INTRACELLULAR CD3 AS A T LINEAGE MARKER IN LEUKEMIA: ROLE OF INTENSITY

EHA Library, Jitka Stancikova, 421091

BLINATUMOMAB EXPERIENCE IN PEDIATRIC ALL TREATMENT: IS IT EFFECTIVE IN EXTRAMEDULLARY DISEASE?

EHA Library, Suleimen Zhumatayev, 421092

LENALIDOMIDE-ASSOCIATED B-ALL RESPONDS WELL TO CVAD AND ANTI-CD22 INOTUZUMAB: A SINGLE INSTITUTION EXPERIENCE

EHA Library, Ximena Bruno, 421093

A PRELIMINARY STUDY ON THE SAFETY AND EFFICACY OF LOW-DOSE ORLOTINIB COMBINED WITH CHEMOTHERAPY IN NEWLY DIAGNOSED PH+ ACUTE B-CELL LYMPHOBLASTIC LEUKEMIA

EHA Library, Yi Wang, 421094

PROGNOSTIC SIGNIFICANCE OF TP53 ALTERATIONS IN CHILDHOOD B-ALL

EHA Library, Yangyang Gao, 421095

FIXED DOSE OF INOTUZUMAB OZOGAMICIN COMBINED WITH VP-BASED CHEMOTHERAPY INDUCES EFFICACY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA OF DIFFERENT STAGES INCLUDING MAINTENANCE

EHA Library, Sijie Tang, 421096

B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: CLINICAL COURSE AND UNUSUAL CERVICAL RELAPSE

EHA Library, Nourhene Guedri, 421097

EFFICACY AND SAFETY OF BLINATUMOMAB BRIDGING THERAPY AFTER INDUCTION FOR NEWLY DIAGNOSED PEDIATRIC B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Ruidong Zhang, 421098

CLONAL EVOLUTION DEFINES PROGNOSTIC STRATIFICATION FOR CENTRAL NERVOUS SYSTEM LEUKEMIA IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Jia Li, 421099

INOTUZUMAB OZOGAMICIN RESCUE TREATMENT IMPROVED THE SURVIVAL OF HIGH-RISK ADULT R/R B-ALL PATIENTS WITH CRITICAL TUMOR SUPPRESSOR GENE ALTERATION

EHA Library, Zihong Cai, 421100

A COMPARATIVE ANALYSIS OF CYTOGENETIC ABERRATIONS, MUTATION PROFILE AND POST INDUCTION MRD IN ETP AND NON ETP T- ACUTE LYMPHOBLASTIC LEUKEMIA.

EHA Library, Sujeet Kumar, 421101

A COMBINED TYROSINE KINASE INHIBITOR AND BLINATUMOMAB APPROACH IN PHILADELPHIA CHROMOSOME-POSITIVE OR PHILADELPHIA CHROMOSOME-LIKE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Miao Miao, 421102

CLINICAL CHARACTERISTICS OF FIRST RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN, ADOLESCENT AND YOUNG ADULTS

EHA Library, Aicha Ben kahla, 421103

THE FIRST YEAR AFTER A NEW DIAGNOSIS OF PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA. TREATMENT STRATEGIES AND DISEASE PROGRESSION THROUGH ITALIAN ADMINISTRATIVE HEALTHCARE DATA

EHA Library, Immacolata Esposito, 421104

DAY 8 GOOD STEROID RESPONSE PREDICTS POST-INDUCTION NEGATIVE MRD STATUS IN PEDIATRIC & AYA ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS TREATED WITH ALL IC-BFM 2009 PROTOCOL: SINGLE-CENTER STUDY FROM INDIA

EHA Library, Adamya Gupta, 421105

REAL-WORLD OUTCOMES OF RELAPSED PHILADELPHIA NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN PATIENTS TREATED UP FRONT WITH A PEDIATRIC-INSPIRED PROTOCOL

EHA Library, Maria Agustina Perusini, 421106

POST-INDUCTION MONOCYTE COUNT PREDICTS LONG TERM SURVIVAL IN YOUNG PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA / LYMPHOBLASTIC LYMPHOMA

EHA Library, Ana Vagos Mata, 421107

THERAPEUTIC RESULTS OF COOPRALL REGIEMEN IN FIRST RELAPSED ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Aicha Ben kahla, 421109

USE OF BLINATUMOMAB AS BRIDGE THERAPY BEFORE ALLOGENEIC BONE MARROW TRANSPLANTATION IN PATIENTS WITH ACUTE B-LYMPHOBLASTIC LEUKEMIA (B-ALL)

EHA Library, Maryna Dubina, 421110

INCIDENCE OF VENOUS THROMBOEMBOLISM AND EFFECT IN MORTALITY IN PATIENTS NEWLY DIAGNOSED WITH PH- ALL TREATED WITH ASPARAGINASE: SINGLE-CENTER RETROSPECTIVE STUDY

EHA Library, Miguel Navarro Sánchez, 421112

HIGH NEUTROPHIL COUNT AT INITIAL DIAGNOSIS PREDICTS POOR PROGNOSIS IN ADULT EARLY T-CELL PRECURSOR LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

EHA Library, Jieping Lin, 421113

PROGNOSTIC IMPACT OF CONCURRENT GENETIC DELETIONS IN IKZF1 AND CDKN2 IN ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, So Yeon Park, 421115

PURINE-DERIVED PHENYLHYDROXAMATE INDUCES CELL DEATH IN AML CELLS

EHA Library, Jorge Carlos, 421116

UNIQUE EPIGENETIC PATTERNS OF DNA HYDROXYMETHYLATION (5HMC) IN AML: A NOVEL MICROARRAY TECHNOLOGY FOR 5HMC PROFILING IN PERIPHERAL BLOOD

EHA Library, Miriam Neaman, 421117

DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF CYTOGENETIC ABNORMALITIES IN ADULT ACUTE MYELOMONOCYTIC LEUKEMIA

EHA Library, Olena Zotova, 421118

SYNERGISTIC EFFECTS OF THE RARALPHA AGONIST TAMIBAROTENE AND THE MENIN INHIBITOR REVUMENIB IN ACUTE MYELOID LEUKEMIA CELLS WITH KMT2A REARRANGEMENT OR NPM1 MUTATION

EHA Library, Maximilian Fleischmann, 421119

A NEW HUMAN ACUTE MYELOID LEUKEMIA CELL LINE SDEY-AML1 WITH KMT2A-MLLT3, IKZF1-EVX1, P53, ETV6 GENE ALTERATIONS AND HIGH TUMORIGENICITY IN NSG MICE

EHA Library, Chenwei Yang, 421120

ABERRANT IMMUNOPHENOTYPIC PROFILES IN ACUTE MYELOID LEUKEMIA

EHA Library, Maha Charfi, 421121

EXPRESSION OF NON-CODING RNA DANCR AND ITS REGULATORY RIBOSOME-BINDING PROTEIN IN ACUTE MYELOID LEUKEMIA

EHA Library, Pi-Han Liao, 421122

MIR-342 GENE METHYLATION AND MUTATIONAL SIGNATURE OF THE ACUTE MYELOID LEUKEMIA

EHA Library, Tatyana Pospelova, 421123

THE DEPENDENCE OF ANEMIA ON THE CONCENTRATION OF CYTOKINES, TNF, TGFΒ1, IN THE ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Vira Barilka, 421124

EXPRESSION ANALYSIS, CLINICAL SIGNIFICANCE AND POTENTIAL FUNCTION OF ALOX5AP IN ACUTE MYELOID LEUKEMIA

EHA Library, Harsh Goel, 421125

SINGLE-CELL TRANSCRIPTOME PROFILING OF M6A REGULATOR-MEDIATED METHYLATION MODIFICATION PATTERNS IN ELDERLY AML PATIENTS

EHA Library, Ruijuan Zhang, 421126

A PROSPECTIVE STUDY TO EVALUATE THE PROGNOSTIC IMPLICATIONS OF MMP-2 GENE IN ACUTE MYELOID LEUKEMIA

EHA Library, Harsh Goel, 421127

THE THERAPEUTIC POTENTIAL OF THE EXON-JUNCTION COMPLEX RNA HELICASE EIF4A3 IN ACUTE MYELOID LEUKEMIA.

EHA Library, Dimitris Kanellis, 421128

THE IMPACT OF PATIENT SPECIFIC CARCINOGENIC EXPOSURES ON TP53 MUTATED MYELOID NEOPLASMS

EHA Library, Katie Liston, 421129

EXPLORING THE ACTIVITY OF VENETOCLAX IN PRIMARY AML CELLS BY MIMICKING THE TUMOR MICROENVIRONMENT.

EHA Library, Jenifer Sanchez, 421130

IMPORTANCE OF CYTOGENETICS IN IDENTIFICATION OF ATYPICAL MECOM GENE REARRANGEMENTS IN PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Isabel Salazar, 421131

INHIBITION OF CDK4/6 AUGMENTS ATRA-INDUCED DIFFERENTIATION ACROSS ACUTE MYELOID LEUKAEMIA SUBTYPES

EHA Library, Rhiannon Newman, 421132

PRMT2 GOVERNS INFLAMMATION IN ACUTE MYELOID LEUKEMIA CELLS

EHA Library, Denis Masnikov, 421133

KMT2A (MLL) GENE AMPLIFICATION IN ACUTE MYELOID LEUKEMIA, SERIE OF THREE CASES AND LITERATURE REVIEW.

EHA Library, María José López de la Osa Velacoracho, 421134

EFFECT AND MECHANISM OF HPK1 INHIBITOR BGB-15025 ON ACUTE MYELOID LEUKEMIA

EHA Library, Shiyu Yang, 421135

STABILITY ASSESSMENT OF FRESH OR CRYOPRESERVED WHOLE BLOOD AND BONE MARROW SAMPLES FROM AML PATIENTS TO MONITOR CD123 RECEPTOR AND IMMUNE CELLS SUBSETS

EHA Library, Maxime Moulard, 421137

CHROMOSOME 11 ABNORMALITIES IN ACUTE MYELOID LEUKEMIA

EHA Library, Ana Franjević, 421138